Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...

Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...

Key Points GAAP revenue reached $2.44 billion in Q2 2025, rising 13.1% year over year (GAAP). Gross and operating margins declined significantly (GAAP), with gross margin down 1.6 percentage points.

Blue Owl Capital shows strong growth and AUM gains, but dilution and a premium valuation raise caution for investors. Find ...

WM Technology, Inc. (NASDAQ: MAPS) Q2 2025 Earnings Call Transcript August 7, 2025 WM Technology, Inc. misses on earnings ...

Year-to-date Net Income has exceeded Adjusted Net Income by $4.1 million, as discrete items have lowered the effective tax ...

GigaCloud Technology Inc. (NASDAQ: GCT) Q2 2025 Earnings Call Transcript August 7, 2025 GigaCloud Technology Inc. beats ...

PG&E Corporation recorded second-quarter 2025 income available for common shareholders of $521 million, or $0.24 per share, ...

Please note that the limited information that follows in this press release is a summary and is not adequate for making an informed investment decision.

Assured Guaranty (AGO) reported Q2 financial results, with a call discussing new business, credit outlooks, market conditions ...